 | • レポートコード：QYR2104Z4418 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、膵臓がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（膵臓がん用承認治療薬、アブラキサン（パクリタキセルアルブミン安定化ナノ粒子製剤）、アフィニトール（エベロリムス）、塩酸エルロチニブ、エベロリムス、5-FU（フルオロウラシル注射）、フルオロウラシル注射、塩酸ゲムシタビン、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・膵臓がん治療薬の市場動向 ・企業の競争状況、市場シェア ・膵臓がん治療薬の種類別市場規模（膵臓がん用承認治療薬、アブラキサン（パクリタキセルアルブミン安定化ナノ粒子製剤）、アフィニトール（エベロリムス）、塩酸エルロチニブ、エベロリムス、5-FU（フルオロウラシル注射）、フルオロウラシル注射、塩酸ゲムシタビン、その他） ・膵臓がん治療薬の用途別市場規模（病院、診療所） ・膵臓がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・膵臓がん治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・膵臓がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・膵臓がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・膵臓がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly and Company、Celgene、Roche、Novartis、Clovis Oncology、Amgen、Merck、Teva Pharmaceutical Industries、Pfizer、PharmaCyte Biotech） ・結論 |
Market Analysis and Insights: Global Pancreatic Cancer Treatment Drugs Market
The global Pancreatic Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pancreatic Cancer Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pancreatic Cancer Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pancreatic Cancer Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pancreatic Cancer Treatment Drugs market.
Global Pancreatic Cancer Treatment Drugs Scope and Market Size
Pancreatic Cancer Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Cancer Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Drugs Approved for Pancreatic Cancer
Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
Afinitor (Everolimus)
Erlotinib Hydrochloride
Everolimus
5-FU (Fluorouracil Injection)
Fluorouracil Injection
Gemcitabine Hydrochloride
Other
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly and Company
Celgene
Roche
Novartis
Clovis Oncology
Amgen
Merck
Teva Pharmaceutical Industries
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Cancer Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs Approved for Pancreatic Cancer
1.2.3 Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
1.2.4 Afinitor (Everolimus)
1.2.5 Erlotinib Hydrochloride
1.2.6 Everolimus
1.2.7 5-FU (Fluorouracil Injection)
1.2.8 Fluorouracil Injection
1.2.9 Gemcitabine Hydrochloride
1.2.10 Other
1.3 Market by Application
1.3.1 Global Pancreatic Cancer Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Cancer Treatment Drugs Market Perspective (2016-2027)
2.2 Pancreatic Cancer Treatment Drugs Growth Trends by Regions
2.2.1 Pancreatic Cancer Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pancreatic Cancer Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Pancreatic Cancer Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Pancreatic Cancer Treatment Drugs Industry Dynamic
2.3.1 Pancreatic Cancer Treatment Drugs Market Trends
2.3.2 Pancreatic Cancer Treatment Drugs Market Drivers
2.3.3 Pancreatic Cancer Treatment Drugs Market Challenges
2.3.4 Pancreatic Cancer Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Cancer Treatment Drugs Players by Revenue
3.1.1 Global Top Pancreatic Cancer Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Pancreatic Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Cancer Treatment Drugs Revenue
3.4 Global Pancreatic Cancer Treatment Drugs Market Concentration Ratio
3.4.1 Global Pancreatic Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Treatment Drugs Revenue in 2020
3.5 Pancreatic Cancer Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Pancreatic Cancer Treatment Drugs Product Solution and Service
3.7 Date of Enter into Pancreatic Cancer Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Cancer Treatment Drugs Breakdown Data by Type
4.1 Global Pancreatic Cancer Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Pancreatic Cancer Treatment Drugs Forecasted Market Size by Type (2022-2027)
5 Pancreatic Cancer Treatment Drugs Breakdown Data by Application
5.1 Global Pancreatic Cancer Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Pancreatic Cancer Treatment Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pancreatic Cancer Treatment Drugs Market Size (2016-2027)
6.2 North America Pancreatic Cancer Treatment Drugs Market Size by Type
6.2.1 North America Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Pancreatic Cancer Treatment Drugs Market Size by Application
6.3.1 North America Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Pancreatic Cancer Treatment Drugs Market Size by Country
6.4.1 North America Pancreatic Cancer Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Pancreatic Cancer Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pancreatic Cancer Treatment Drugs Market Size (2016-2027)
7.2 Europe Pancreatic Cancer Treatment Drugs Market Size by Type
7.2.1 Europe Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Pancreatic Cancer Treatment Drugs Market Size by Application
7.3.1 Europe Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Pancreatic Cancer Treatment Drugs Market Size by Country
7.4.1 Europe Pancreatic Cancer Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Pancreatic Cancer Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pancreatic Cancer Treatment Drugs Market Size (2016-2027)
9.2 Latin America Pancreatic Cancer Treatment Drugs Market Size by Type
9.2.1 Latin America Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Pancreatic Cancer Treatment Drugs Market Size by Application
9.3.1 Latin America Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Pancreatic Cancer Treatment Drugs Market Size by Country
9.4.1 Latin America Pancreatic Cancer Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Pancreatic Cancer Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Pancreatic Cancer Treatment Drugs Introduction
11.1.4 Eli Lilly and Company Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.1.5 Eli Lilly and Company Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Pancreatic Cancer Treatment Drugs Introduction
11.2.4 Celgene Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Pancreatic Cancer Treatment Drugs Introduction
11.3.4 Roche Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Pancreatic Cancer Treatment Drugs Introduction
11.4.4 Novartis Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Clovis Oncology
11.5.1 Clovis Oncology Company Details
11.5.2 Clovis Oncology Business Overview
11.5.3 Clovis Oncology Pancreatic Cancer Treatment Drugs Introduction
11.5.4 Clovis Oncology Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.5.5 Clovis Oncology Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Pancreatic Cancer Treatment Drugs Introduction
11.6.4 Amgen Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Pancreatic Cancer Treatment Drugs Introduction
11.7.4 Merck Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Details
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Pancreatic Cancer Treatment Drugs Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Pancreatic Cancer Treatment Drugs Introduction
11.9.4 Pfizer Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 PharmaCyte Biotech
11.10.1 PharmaCyte Biotech Company Details
11.10.2 PharmaCyte Biotech Business Overview
11.10.3 PharmaCyte Biotech Pancreatic Cancer Treatment Drugs Introduction
11.10.4 PharmaCyte Biotech Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021)
11.10.5 PharmaCyte Biotech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pancreatic Cancer Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs Approved for Pancreatic Cancer
Table 3. Key Players of Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
Table 4. Key Players of Afinitor (Everolimus)
Table 5. Key Players of Erlotinib Hydrochloride
Table 6. Key Players of Everolimus
Table 7. Key Players of 5-FU (Fluorouracil Injection)
Table 8. Key Players of Fluorouracil Injection
Table 9. Key Players of Gemcitabine Hydrochloride
Table 10. Key Players of Other
Table 11. Global Pancreatic Cancer Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Pancreatic Cancer Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Pancreatic Cancer Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Pancreatic Cancer Treatment Drugs Market Share by Regions (2016-2021)
Table 15. Global Pancreatic Cancer Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Pancreatic Cancer Treatment Drugs Market Share by Regions (2022-2027)
Table 17. Pancreatic Cancer Treatment Drugs Market Trends
Table 18. Pancreatic Cancer Treatment Drugs Market Drivers
Table 19. Pancreatic Cancer Treatment Drugs Market Challenges
Table 20. Pancreatic Cancer Treatment Drugs Market Restraints
Table 21. Global Pancreatic Cancer Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Pancreatic Cancer Treatment Drugs Market Share by Players (2016-2021)
Table 23. Global Top Pancreatic Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Treatment Drugs as of 2020)
Table 24. Ranking of Global Top Pancreatic Cancer Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Pancreatic Cancer Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Pancreatic Cancer Treatment Drugs Product Solution and Service
Table 28. Date of Enter into Pancreatic Cancer Treatment Drugs Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 32. Global Pancreatic Cancer Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Pancreatic Cancer Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 36. Global Pancreatic Cancer Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Pancreatic Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Pancreatic Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Pancreatic Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Pancreatic Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Pancreatic Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Pancreatic Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 68. Eli Lilly and Company Company Details
Table 69. Eli Lilly and Company Business Overview
Table 70. Eli Lilly and Company Pancreatic Cancer Treatment Drugs Product
Table 71. Eli Lilly and Company Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly and Company Recent Development
Table 73. Celgene Company Details
Table 74. Celgene Business Overview
Table 75. Celgene Pancreatic Cancer Treatment Drugs Product
Table 76. Celgene Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 77. Celgene Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Pancreatic Cancer Treatment Drugs Product
Table 81. Roche Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Pancreatic Cancer Treatment Drugs Product
Table 86. Novartis Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Clovis Oncology Company Details
Table 89. Clovis Oncology Business Overview
Table 90. Clovis Oncology Pancreatic Cancer Treatment Drugs Product
Table 91. Clovis Oncology Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 92. Clovis Oncology Recent Development
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Pancreatic Cancer Treatment Drugs Product
Table 96. Amgen Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 97. Amgen Recent Development
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Pancreatic Cancer Treatment Drugs Product
Table 101. Merck Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Teva Pharmaceutical Industries Company Details
Table 104. Teva Pharmaceutical Industries Business Overview
Table 105. Teva Pharmaceutical Industries Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 106. Teva Pharmaceutical Industries Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Pancreatic Cancer Treatment Drugs Product
Table 110. Pfizer Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 111. Pfizer Recent Development
Table 112. PharmaCyte Biotech Company Details
Table 113. PharmaCyte Biotech Business Overview
Table 114. PharmaCyte Biotech Pancreatic Cancer Treatment Drugs Product
Table 115. PharmaCyte Biotech Revenue in Pancreatic Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 116. PharmaCyte Biotech Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Cancer Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Drugs Approved for Pancreatic Cancer Features
Figure 3. Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation) Features
Figure 4. Afinitor (Everolimus) Features
Figure 5. Erlotinib Hydrochloride Features
Figure 6. Everolimus Features
Figure 7. 5-FU (Fluorouracil Injection) Features
Figure 8. Fluorouracil Injection Features
Figure 9. Gemcitabine Hydrochloride Features
Figure 10. Other Features
Figure 11. Global Pancreatic Cancer Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. Pancreatic Cancer Treatment Drugs Report Years Considered
Figure 15. Global Pancreatic Cancer Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Pancreatic Cancer Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Pancreatic Cancer Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 18. Global Pancreatic Cancer Treatment Drugs Market Share by Regions (2022-2027)
Figure 19. Global Pancreatic Cancer Treatment Drugs Market Share by Players in 2020
Figure 20. Global Top Pancreatic Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Treatment Drugs as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Pancreatic Cancer Treatment Drugs Revenue in 2020
Figure 22. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 23. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 24. North America Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Pancreatic Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 26. North America Pancreatic Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 27. North America Pancreatic Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 28. United States Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Pancreatic Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 32. Europe Pancreatic Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 33. Europe Pancreatic Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 34. Germany Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Pancreatic Cancer Treatment Drugs Market Share by Region (2016-2027)
Figure 44. China Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Pancreatic Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 52. Latin America Pancreatic Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 53. Latin America Pancreatic Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 54. Mexico Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Pancreatic Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 60. Turkey Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Pancreatic Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Eli Lilly and Company Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 64. Celgene Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 67. Clovis Oncology Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 70. Teva Pharmaceutical Industries Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 72. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Cancer Treatment Drugs Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の膵臓がん治療薬市場 2021：企業別、地域別、種類・用途別 The Pancreatic Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Market The global Pancreatic Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Market The global Pancreatic Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の膵臓がん治療薬市場規模・現状・予測（2021年-2027年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …